Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Post-Kidney Transplantation Results After Circulatory or Brain Death Without Pre-Mortem Heparin Administration

J. Roman, F. Jalůvka, P. Ostruszka, P. Jelínek, J. Hrubovčák, P. Havránek, A. Vrtková, Z. Lys, J. Dědochová, V. Procházka

. 2022 ; 28 (-) : e936877. [pub] 20220704

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22025276

BACKGROUND Kidney donation after circulatory death (DCD) follows confirmation of death using cardiorespiratory criteria, while donation after brain death (DBD) uses neurological criteria. DBD and DCD donors are the main sources of grafts for transplantation. This retrospective cohort study from a single center in the Czech Republic aimed to compare 5-year post-transplantation outcomes after DCD and DBD transplantation without pre-mortem heparin administration. MATERIAL AND METHODS A total of 227 recipients with matched donors enrolled in the transplantation program at our institution between 2015 and 2019 were analyzed. Following the application of the inclusion criteria, 99 recipients and 94 matched donors were finally included in the study. RESULTS The duration of cold ischemia (median 961 vs 1100 min, P=0.028) and the perfusion with the preservation solution (median 11 vs 22 min, P<0.001) was statistically significantly shorter in DBD than in DCD grafts. The 1-year survival rates were 97.5% (95% CI 94.1-100.0%) and 90.0% (95% CI: 77.8-100.0%) for DBD and DCD recipients, respectively. The 3-year survival rates were 91.9 (95% CI: 86.0-98.4) and 90.0 (95% CI: 77.8-100.0) for the DBD and DCD groups, respectively. The overall difference in survival between the 2 groups of patients was not statistically significant (P=0.750) nor was disease-free survival (P=0.370). CONCLUSIONS This retrospective study from a single center showed similar 5-year results after kidney transplantation for DCD and DBD donors without pre-mortem heparin administration, including the time to graft failure and patient survival.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025276
003      
CZ-PrNML
005      
20221031101317.0
007      
ta
008      
221017s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.12659/MSM.936877 $2 doi
035    __
$a (PubMed)35786635
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Roman, Jan $u Clinic of Surgery, University Hospital Ostrava, Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000167399966
245    10
$a Post-Kidney Transplantation Results After Circulatory or Brain Death Without Pre-Mortem Heparin Administration / $c J. Roman, F. Jalůvka, P. Ostruszka, P. Jelínek, J. Hrubovčák, P. Havránek, A. Vrtková, Z. Lys, J. Dědochová, V. Procházka
520    9_
$a BACKGROUND Kidney donation after circulatory death (DCD) follows confirmation of death using cardiorespiratory criteria, while donation after brain death (DBD) uses neurological criteria. DBD and DCD donors are the main sources of grafts for transplantation. This retrospective cohort study from a single center in the Czech Republic aimed to compare 5-year post-transplantation outcomes after DCD and DBD transplantation without pre-mortem heparin administration. MATERIAL AND METHODS A total of 227 recipients with matched donors enrolled in the transplantation program at our institution between 2015 and 2019 were analyzed. Following the application of the inclusion criteria, 99 recipients and 94 matched donors were finally included in the study. RESULTS The duration of cold ischemia (median 961 vs 1100 min, P=0.028) and the perfusion with the preservation solution (median 11 vs 22 min, P<0.001) was statistically significantly shorter in DBD than in DCD grafts. The 1-year survival rates were 97.5% (95% CI 94.1-100.0%) and 90.0% (95% CI: 77.8-100.0%) for DBD and DCD recipients, respectively. The 3-year survival rates were 91.9 (95% CI: 86.0-98.4) and 90.0 (95% CI: 77.8-100.0) for the DBD and DCD groups, respectively. The overall difference in survival between the 2 groups of patients was not statistically significant (P=0.750) nor was disease-free survival (P=0.370). CONCLUSIONS This retrospective study from a single center showed similar 5-year results after kidney transplantation for DCD and DBD donors without pre-mortem heparin administration, including the time to graft failure and patient survival.
650    12
$a mozková smrt $7 D001926
650    _2
$a přežívání štěpu $7 D006085
650    _2
$a heparin $7 D006493
650    _2
$a lidé $7 D006801
650    12
$a transplantace ledvin $7 D016030
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jalůvka, František $u Clinic of Surgery, University Hospital Ostrava, Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Ostruszka, Petr $u Clinic of Surgery, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Jelínek, Petr $u Clinic of Surgery, University Hospital Ostrava, Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/000000023988024X
700    1_
$a Hrubovčák, Ján $u Clinic of Surgery, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Havránek, Pavel $u Clinic of Surgery, University Hospital Ostrava, Ostrava, Czech Republic $u Transplantation Center, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Vrtková, Adéla $u Department of Applied Mathematics, Faculty of Electrical Engineering and Computer Science, VSB - Technical University of Ostrava, Ostrava, Czech Republic $u Department of The Deputy Director for Science, Research, and Education, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Lys, Zdeněk $u Transplantation Center, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Dědochová, Jarmila $u Transplantation Center, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Procházka, Václav $u Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Radiology, University Hospital Ostrava, Ostrava, Czech Republic
773    0_
$w MED00003251 $t Medical Science Monitor $x 1643-3750 $g Roč. 28, č. - (2022), s. e936877
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35786635 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031101314 $b ABA008
999    __
$a ok $b bmc $g 1854800 $s 1176566
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 28 $c - $d e936877 $e 20220704 $i 1643-3750 $m Medical Science Monitor $n Med Sci Monit $x MED00003251
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Možnosti archivace